SCHEMBL31728368

SCHEMBL31728368

[2H]C([2H])([2H])n1cnc(C(C)Oc2c(OC(F)F)cc(Br)c3ncnc(N)c23)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728340 0.90 SRC (0.33) —
SCHEMBL31728401 0.83 SRC (0.39) —
SCHEMBL31728341 0.81 SRC (0.34) —
SCHEMBL31728415 0.79 — —
SCHEMBL31727804 0.79 SRC (0.37) —
SCHEMBL31728101 0.78 SRC (0.34) —
SCHEMBL31727797 0.75 PIK3CD (0.33) —
SCHEMBL31728046 0.75 SRC (0.37) —
SCHEMBL31728811 0.73 SRC (0.36) —
SCHEMBL31727763 0.73 SRC (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback